Topics
April 2012 | feature Stories
Novel Optogenetic Therapy May Restore Vision After Retinal Degeneration
Researchers have developed an approach to restore vision using a component of green algae.
Callan Navitsky, Associate Editor
July 30, 2026
Spanish Researchers Show Photoswitchable Drug Candidates Restore Vision-Related Behaviors in Retinal Degeneration Models
July 28, 2026
CHMP Backs Roche’s Susvimo for Wet AMD, European Commission Decision Pending
July 27, 2026
Aravind Eye Care System, Alcon Launch Global Vitreoretinal Surgery Training Center in India
July 24, 2026
FDA Approves Outlook Therapeutics' Lytenava as First Ophthalmic Bevacizumab for Wet AMD
May/June 2026 Insert
Editorially Independent Content, Supported With Advertising From Astellas
Supported by Zeiss
Editorially independent supported by Abbvie and Regenxbio
May/June 2026 Supplement
Editorially independent content supported by advertising from Genentech
Free Print Subscription
Email Newsletter
Conference Calendar
